• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-17A 和白细胞介素-17E 在多发性骨髓瘤患者中的作用。

The role of Interleukin-17A and Interleukin-17E in multiple myeloma patients.

机构信息

Department of Human Anatomy, Medical University of Bialystok, Bialystok, Poland.

出版信息

Med Sci Monit. 2012 Jan;18(1):BR54-59. doi: 10.12659/msm.882204.

DOI:10.12659/msm.882204
PMID:22207110
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3560674/
Abstract

BACKGROUND

Tumor growth in multiple myeloma (MM) is regulated by the cytokine networks which are produced by myeloma cells and the microenvironment of the bone marrow. Interleukin-17 (IL-17) is implicated in the increased angiogenesis in the bone marrow of MM. Recent studies reported elevated levels of interleukin 17A (IL-17A) in the sera of patients with advanced stages according to Durie-Salmon classification.

MATERIAL/METHODS: We compared the concentration of IL-17A and IL-17E in the blood serum of 34 newly diagnosed MM patients with healthy subjects' sera. We also evaluated the concentration of IL-17A and IL-17E in the blood serum of MM patients and the relation to the percentage of plasma cells and other clinical parameters. The concentration of IL-17E and IL-17A of healthy subjects and patients with MM was assessed by enzyme-linked immunosorbent assay (ELISA).

RESULTS

Our data confirm that IL-17A and IL-17E serum levels were significantly higher in all MM patients and also in patients with advanced stage compared with healthy subjects. We found the correlation between serum levels of IL-17A in MM patients and percentage of plasma cells. Our results also showed that if serum levels of IL-17E were higher in MM patients, the percentage of plasma cells and beta-2-microglobulin levels were lower.

CONCLUSIONS

The IL-17 family of cytokines may suppress or promote tumor growth. There seems to be some balance between the effects of IL-17A and IL-17E. The role of increased levels of IL-17E needs further investigation to understand its role in the pathobiology of MM.

摘要

背景

多发性骨髓瘤(MM)中的肿瘤生长受骨髓瘤细胞产生的细胞因子网络和骨髓微环境调节。白细胞介素-17(IL-17)与 MM 骨髓中血管生成增加有关。最近的研究报告称,根据 Durie-Salmon 分类,处于晚期的患者血清中白细胞介素 17A(IL-17A)水平升高。

材料/方法:我们比较了 34 例新诊断的 MM 患者和健康受试者血清中 IL-17A 和 IL-17E 的浓度。我们还评估了 MM 患者血清中 IL-17A 和 IL-17E 的浓度及其与浆细胞百分比和其他临床参数的关系。采用酶联免疫吸附试验(ELISA)检测健康受试者和 MM 患者的 IL-17E 和 IL-17A 浓度。

结果

我们的数据证实,所有 MM 患者和晚期患者的血清 IL-17A 和 IL-17E 水平均显著高于健康受试者。我们发现 MM 患者血清中 IL-17A 水平与浆细胞百分比之间存在相关性。我们的结果还表明,如果 MM 患者血清中 IL-17E 水平较高,则浆细胞百分比和β-2-微球蛋白水平较低。

结论

白细胞介素-17 细胞因子家族可能抑制或促进肿瘤生长。IL-17A 和 IL-17E 的作用之间似乎存在某种平衡。需要进一步研究增加的 IL-17E 水平,以了解其在 MM 发病机制中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7bd/3560674/6ff606501a83/medscimonit-18-1-BR54-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7bd/3560674/4aa5a675b258/medscimonit-18-1-BR54-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7bd/3560674/6ff606501a83/medscimonit-18-1-BR54-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7bd/3560674/4aa5a675b258/medscimonit-18-1-BR54-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7bd/3560674/6ff606501a83/medscimonit-18-1-BR54-g002.jpg

相似文献

1
The role of Interleukin-17A and Interleukin-17E in multiple myeloma patients.白细胞介素-17A 和白细胞介素-17E 在多发性骨髓瘤患者中的作用。
Med Sci Monit. 2012 Jan;18(1):BR54-59. doi: 10.12659/msm.882204.
2
Clinical associations between IL-17 family cytokines and periodontitis and potential differential roles for IL-17A and IL-17E in periodontal immunity.白细胞介素-17家族细胞因子与牙周炎之间的临床关联以及白细胞介素-17A和白细胞介素-17E在牙周免疫中的潜在差异作用。
Inflamm Res. 2014 Dec;63(12):1001-12. doi: 10.1007/s00011-014-0776-7. Epub 2014 Nov 5.
3
The effect of periodontal scaling and root polishing on serum IL-17E concentrations and the IL-17A:IL-17E ratio.牙周洁治和根面平整对血清白细胞介素-17E浓度及白细胞介素-17A:白细胞介素-17E比值的影响。
Clin Oral Investig. 2016 Dec;20(9):2529-2537. doi: 10.1007/s00784-016-1749-8. Epub 2016 Feb 18.
4
Cytokine profiles in patients with newly diagnosed multiple myeloma: Survival is associated with IL-6 and IL-17A levels.新诊断多发性骨髓瘤患者的细胞因子谱:生存与 IL-6 和 IL-17A 水平相关。
Cytokine. 2021 Feb;138:155358. doi: 10.1016/j.cyto.2020.155358. Epub 2020 Nov 10.
5
Chosen IL-17 family proteins in neutrophils of patients with oral inflammation.口腔炎症患者中性粒细胞中选定的白细胞介素-17家族蛋白。
Adv Med Sci. 2008;53(2):326-30. doi: 10.2478/v10039-008-0044-6.
6
Effects of smoking on the gingival crevicular fluid levels of interleukin-17A, interleukin-17E, and oxidative stress following periodontal treatment process.吸烟对牙周治疗过程中龈沟液中白细胞介素-17A、白细胞介素-17E 和氧化应激的影响。
J Periodontal Res. 2021 Apr;56(2):388-396. doi: 10.1111/jre.12831. Epub 2021 Jan 17.
7
Expression of subtypes of interleukin-17 ligands and receptors in patients with B-cell chronic lymphocytic leukemia.白细胞介素-17配体和受体亚型在B细胞慢性淋巴细胞白血病患者中的表达
Clin Lab. 2014;60(10):1677-83. doi: 10.7754/clin.lab.2014.131107.
8
IL-17 family cytokines in neutrophils of patients with oral epithelial squamous cell carcinoma.口腔上皮鳞状细胞癌患者中性粒细胞中的白细胞介素-17家族细胞因子
Neoplasma. 2009;56(2):96-100. doi: 10.4149/neo_2009_02_96.
9
IL-17E production is elevated in the lungs of Balb/c mice in the later stages of Chlamydia muridarum infection and re-infection.在沙眼衣原体感染和再感染的后期,巴尔夫/c 小鼠肺部的白细胞介素 17E 产量升高。
In Vivo. 2013 Nov-Dec;27(6):787-92.
10
High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis.高白细胞介素-17E和低白细胞介素-17C的皮肤表达确定了硬斑病和系统性硬化症共有的纤维化特异性基序。
PLoS One. 2014 Aug 19;9(8):e105008. doi: 10.1371/journal.pone.0105008. eCollection 2014.

引用本文的文献

1
The role of IL-17-related signaling in myelomagenesis, disease prognosis/progression, and therapeutic approach-a scoping review.白细胞介素-17相关信号通路在骨髓瘤发生、疾病预后/进展及治疗方法中的作用——一项综述
Clin Exp Med. 2025 Jun 9;25(1):194. doi: 10.1007/s10238-025-01728-6.
2
The IL-17 family in diseases: from bench to bedside.IL-17 家族与疾病:从基础到临床。
Signal Transduct Target Ther. 2023 Oct 11;8(1):402. doi: 10.1038/s41392-023-01620-3.
3
Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple Sclerosis.

本文引用的文献

1
Expression of Th-17 and RORγt mRNA in Behçet's Disease.Behçet 病中 Th-17 和 RORγt mRNA 的表达。
Med Sci Monit. 2011 Apr;17(4):CR227-34. doi: 10.12659/msm.881720.
2
A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma.IL-17 产生淋巴细胞在多发性骨髓瘤溶骨性骨病中的新作用。
Blood. 2010 Nov 4;116(18):3554-63. doi: 10.1182/blood-2010-05-283895. Epub 2010 Jul 27.
3
Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma.
多发性硬化症患者的细胞特异性表观遗传年龄加速评估。
Neurology. 2023 Aug 15;101(7):e679-e689. doi: 10.1212/WNL.0000000000207489. Epub 2023 Aug 4.
4
New insights into the function of Interleukin-25 in disease pathogenesis.白细胞介素-25在疾病发病机制中的功能新见解。
Biomark Res. 2023 Apr 1;11(1):36. doi: 10.1186/s40364-023-00474-9.
5
High serum IL-17A is associated with bone destruction in newly diagnosed multiple myeloma patients.血清白细胞介素-17A水平升高与新诊断的多发性骨髓瘤患者的骨质破坏有关。
Front Oncol. 2022 Aug 31;12:936670. doi: 10.3389/fonc.2022.936670. eCollection 2022.
6
Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients.免疫特征分析对多发性骨髓瘤患者生存的预测作用。
Front Immunol. 2021 Jul 5;12:663748. doi: 10.3389/fimmu.2021.663748. eCollection 2021.
7
Interleukin-25: New perspective and state-of-the-art in cancer prognosis and treatment approaches.白细胞介素-25:癌症预后和治疗方法的新视角和最新进展。
Cancer Med. 2021 Aug;10(15):5191-5202. doi: 10.1002/cam4.4060. Epub 2021 Jun 15.
8
Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17/IL-17R-JAK2/STAT3 signaling pathway.自噬通过IL-17/IL-17R-JAK2/STAT3信号通路影响奥沙利铂诱导的肝癌细胞凋亡。
Oncol Lett. 2017 Feb;13(2):770-776. doi: 10.3892/ol.2016.5476. Epub 2016 Dec 8.
9
The Low Expression of IL-37 Involved in Multiple Myeloma - Associated Angiogenesis.白细胞介素-37低表达与多发性骨髓瘤相关血管生成有关。
Med Sci Monit. 2016 Nov 3;22:4164-4168. doi: 10.12659/msm.897451.
10
Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma.靶向白细胞介素-17A治疗多发性骨髓瘤:骨髓瘤一种潜在的新型治疗方法。
Leukemia. 2016 Feb;30(2):379-89. doi: 10.1038/leu.2015.228. Epub 2015 Aug 21.
TH17 细胞产生的白细胞介素-17 促进骨髓瘤细胞生长并抑制多发性骨髓瘤中的免疫功能。
Blood. 2010 Jul 1;115(26):5385-92. doi: 10.1182/blood-2009-10-246660. Epub 2010 Apr 15.
4
IL-17 family cytokines in neutrophils of patients with oral epithelial squamous cell carcinoma.口腔上皮鳞状细胞癌患者中性粒细胞中的白细胞介素-17家族细胞因子
Neoplasma. 2009;56(2):96-100. doi: 10.4149/neo_2009_02_96.
5
Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma.树突状细胞介导了富含骨髓瘤患者骨髓中的多功能人白细胞介素17产生细胞(Th17-1细胞)的诱导。
Blood. 2008 Oct 1;112(7):2878-85. doi: 10.1182/blood-2008-03-143222. Epub 2008 Jul 30.
6
Regulatory mechanisms of helper T cell differentiation: new lessons learned from interleukin 17 family cytokines.辅助性T细胞分化的调控机制:从白细胞介素17家族细胞因子中获得的新认识
Pharmacol Ther. 2008 Mar;117(3):374-84. doi: 10.1016/j.pharmthera.2007.12.003. Epub 2008 Jan 19.
7
Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma.血清白细胞介素-17及其与多发性骨髓瘤血管生成因子的关系。
Eur J Intern Med. 2006 Oct;17(6):412-6. doi: 10.1016/j.ejim.2006.02.012.
8
The IL-17 cytokine family members are inhibitors of human hematopoietic progenitor proliferation.白细胞介素-17细胞因子家族成员是人类造血祖细胞增殖的抑制剂。
Blood. 2006 Jul 15;108(2):770. doi: 10.1182/blood-2006-01-0292.
9
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.产生白细胞介素17的CD4+效应T细胞通过不同于1型和2型辅助性T细胞谱系的途径发育。
Nat Immunol. 2005 Nov;6(11):1123-32. doi: 10.1038/ni1254. Epub 2005 Oct 2.
10
Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells.白细胞介素-17增强碱性成纤维细胞生长因子、肝细胞生长因子和血管内皮生长因子诱导的血管内皮细胞生长。
Immunol Lett. 2005 May 15;98(2):189-93. doi: 10.1016/j.imlet.2004.11.012. Epub 2004 Dec 8.